Global Primary Immunodeficiency Diseases Market US$ 7 Billion by 2023

The global primary immunodeficiency diseases market expected to reach US$ 7 billion by 2023, growing at CAGR 6.7% over the forecast period 2017-2021, due to higher incidence of primary immunodeficiency disorders worldwide.
https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/

The global primary immunodeficiency diseases market report estimates the market size in US$ million for 2015-2023, and forecasts growth trends over a period of 2018-2023. The market for key market segments has been estimated based on epidemiology approach considering patient diagnosis rates, patient treatment rate (IVIG/SCIG), average cost of treatment by regions. The highlights of the report include global number of PID patients, by disease (including subclasses), global number of patient population for treatment or therapy, global number of PID patients, by 15 most commonly identified PIDs by region, and by country, and PID patient’s gender and age by global comparative analysis. The global primary immunodeficiency disease (PIDD or PID or PI) market is dominated by North America and Europe, collectively accounting for major share of the market in 2016. National PID registries worldwide, increasing healthcare expenditure and government support are the major factors driving the global primary immunodeficiency diseases market during the forecast period.

Browse Primary Immunodeficiency Diseases Market by Disease Type (Antibody Deficiency – Agammaglobulinaemia, Common Variable Immune Deficiency, IgG Subclass Deficiency, SIgAD; Cellular Immunodeficiency – Ataxia Telangiectasia, DiGeorge Syndrome, Hyper IgM Syndromes, Wiskott-Aldrich Syndrome; Innate Immune Disorders – Complement Deficiencies, and Hyper IgE Syndrome) and Test Type (Blood and Prenatal Testing), and Treatment Type (Immunoglobulin Replacement Therapy, Antibiotics Therapy, Stem Cell and Gene Therapy) and Forecast 2015-2023.

The report also provides the detailed market landscape and profiles of major competitors in the global market including company overview, financial snapshot, major products and services offered, and recent trends in strategic management. The major companies profiled in the report include Baxter nternational, Inc., Bio Products Laboratory, Biotest AG, CSL Behring LLC, Grifols S.A., Kedrion S.p.A., LFB S.A., Octapharma AG, and others.

1. Disease Type
1.1. Antibody Deficiency
1.1.1. Agammaglobulinaemia
1.1.2. Common Variable Immune Deficiency
1.1.3. IgG Subclass Deficiency
1.1.4. Selective IgA Deficiency (SIgAD)
1.1.5. Others
1.2. Cellular Immunodeficiency
1.2.1. Ataxia Telangiectasia
1.2.2. DiGeorge Syndrome
1.2.3. Hyper IgM Syndromes
1.2.4. Wiskott-Aldrich Syndrome
1.2.5. Others
1.3. Innate Immune Disorder
1.3.1. Complement Deficiencies
1.3.2. Hyper IgE Syndrome
1.3.3. Others

2. Test Type
2.1. Blood Testing
2.2. Prenatal Testing

3. Treatment Type
3.1. Immunoglobulin Replacement Therapy
3.2. Antibiotics Therapy
3.3. Stem cell and Gene Therapy
3.4. Others

4. Geography (Region, Country)
4.1. North America (U.S., Canada)
4.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
4.3. Asia Pacific (Japan, China, India, Rest of APAC)
4.4. Latin America (Brazil, Mexico, Rest of LA)
4.5. Rest of the World

5. Company Profiles
5.1. Baxter International, Inc.
5.2. Bio Products Laboratory
5.3. Biotest AG
5.4. CSL Behring LLC
5.5. Grifols S.A.
5.6. Kedrion S.p.A.
5.7. LFB S.A.
5.8. Octapharma AG

To request Table of Contents and Sample Pages of this report visit:
https://www.ihealthcareanalyst.com/report/primary-immunodeficiency-diseases-market/

iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare IT, healthcare services, medical devices, medical equipment, and pharmaceuticals.

In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.

Ana Aitawa
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
https://www.ihealthcareanalyst.com

This release was published on openPR.